Aging of Preleukemic Thymocytes Drives CpG Island Hypermethylation in T-cell Acute Lymphoblastic Leukemia
Overview
Oncology
Authors
Affiliations
Cancer cells display DNA hypermethylation at specific CpG islands in comparison to their normal healthy counterparts, but the mechanism that drives this so-called CpG island methylator phenotype (CIMP) remains poorly understood. Here, we show that CpG island methylation in human T-cell acute lymphoblastic leukemia (T-ALL) mainly occurs at promoters of Polycomb Repressor Complex 2 (PRC2) target genes that are not expressed in normal or malignant T-cells and which display a reciprocal association with H3K27me3 binding. In addition, we revealed that this aberrant methylation profile reflects the epigenetic history of T-ALL and is established already in pre-leukemic, self-renewing thymocytes that precede T-ALL development. Finally, we unexpectedly uncover that this age-related CpG island hypermethylation signature in T-ALL is completely resistant to the FDA-approved hypomethylating agent Decitabine. Altogether, we here provide conceptual evidence for the involvement of a pre-leukemic phase characterized by self-renewing thymocytes in the pathogenesis of human T-ALL.
Liquid-liquid phase separation in diseases.
Zhang X, Yuan L, Zhang W, Zhang Y, Wu Q, Li C MedComm (2020). 2024; 5(7):e640.
PMID: 39006762 PMC: 11245632. DOI: 10.1002/mco2.640.
Transient Differentiation-State Plasticity Occurs during Acute Lymphoblastic Leukemia Initiation.
Poort V, Hagelaar R, van Roosmalen M, Trabut L, Buijs-Gladdines J, van Wijk B Cancer Res. 2024; 84(16):2720-2733.
PMID: 38885294 PMC: 11325147. DOI: 10.1158/0008-5472.CAN-24-1090.
Building Minimized Epigenetic Clock by iPlex MassARRAY Platform.
Davydova E, Perenkov A, Vedunova M Genes (Basel). 2024; 15(4).
PMID: 38674360 PMC: 11049545. DOI: 10.3390/genes15040425.
Tet2 is a tumor suppressor in the preleukemic phase of T-cell acute lymphoblastic leukemia.
De Coninck S, Roels J, Lintermans B, TSas S, Taghon T, Curtis D Blood Adv. 2024; 8(11):2646-2649.
PMID: 38536906 PMC: 11157202. DOI: 10.1182/bloodadvances.2023011970.
Overexpression of Lmo2 initiates T-lymphoblastic leukemia via impaired thymocyte competition.
Abdulla H, Alserihi R, Flensburg C, Abeysekera W, Luo M, Gray D J Exp Med. 2023; 220(6).
PMID: 36920307 PMC: 10037042. DOI: 10.1084/jem.20212383.